Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Avoid Slam: Clearing the Street for the Eventual fate of Standard Size Trucks - 22024 Watch Gathering: The Best Watches of the Year
- 3What to know about cheese voluntarily recalled in 20 states
- 4Why are malnutrition deaths soaring in America?
- 5Find the Abilities Required for Advanced Advertising Position
- One-third of asylum applications by Iranians approved in Germany
- Best Veggie lover Dinner: What's Your Plant-Based Pick?
- The most effective method to Help a Friend or family member Determined to have Cellular breakdown in the lungs
- What to know about King Charles III's cancer treatment and his message to the public
- New heart disease calculator predicts 30-year risk for young adults
- Warming winters lead to more nitrate pollution in the drinking water near farms
- Spots to Go Hang Floating
- Vote in favor of Your #1 4\u00d74 SUVs
- Luigi Mangione‘s lawyers say Bondi’s death penalty decision was tainted by conflict of interest
